Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03723018 · ClinicalTrials.gov registry record · NA
Me-GC: A Randomized Controlled Trial of Meditation for Genetic Counselors
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 605
- Enrollment target
NCT03723018: Completed NA study, sponsored by Stanford University.
NCT03723018 is a NA study that has completed, run by Stanford University. The registered enrollment target is 605 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03723018, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 605 participants
- Enrollment target
Study Summary
This study is designed to determine whether meditation is beneficial for genetic counselors and genetic counseling students. The main goal is to see if meditation can help with professional well-being (burnout for genetic counselors, stress for genetic counseling students). The investigators will also explore whether meditation has other benefits for the genetic counseling profession.
Primary Outcome
The primary outcome for genetic counselors is burnout, measured with the Professional Fulfillment Inventory
Interventions
- BEHAVIORAL Meditation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 605 participants |
| Start Date | 2019-09-05 |
| Est. Completion | 2021-05-14 |
| Phase | NA |
What the finished NCT03723018 record still lists
NCT03723018 is an interventional study that assigns participants to a tested intervention. The registered 605 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 1 intervention - of which Meditation is the first listed.
NCT03723018 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03723018 about?
NCT03723018 is a clinical study titled "Me-GC: A Randomized Controlled Trial of Meditation for Genetic Counselors". This study is designed to determine whether meditation is beneficial for genetic counselors and genetic counseling students. The main goal is to see if meditation can help with professional well-being (burnout for genetic counselors, stress for genetic counseling students). The investigators will al...
What is the current status of trial NCT03723018?
This trial is currently completed. It is a NA study. The enrollment target is 605 participants. The study started on 2019-09-05. Estimated completion is 2021-05-14.
What interventions are being tested in trial NCT03723018?
The interventions under investigation include: Meditation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03723018?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03723018's enrollment target sits among peer trials
605 162nd of 2000 higher than 1,839 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02342444 · 606 participants · Phase 4
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
- NCT03849443 · 604 participants · Early Phase 1
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
- NCT05238922 · 604 participants · Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- NCT06040541 · 604 participants · Phase 1
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI